Contact an Interstate Health location near you to get started today
Both injections carry the normal risks of any injectable, but the bigger concern with unlicensed products is that complications are harder to predict and harder to treat
If youre ready to see whether you qualify, take the free assessment quiz and take the next step
It is continuing the development of an oral GIPR antagonist candidate (PF-07976016) in Phase 2, and maintains an earlier-stage obesity pipeline
According to the literature, the prevalence of depression is significantly higher in patients with type 2 diabetes than in those without diabetes (17.6% vs
Obesity and high body fat can contribute to the recurrence of certain cancers, such as colon, rectum, gastric, hepatocellular, gallbladder, pancreatic, kidney, oesophageal, meningioma, thyroid, endometrial, ovarian, and post-menopausal breast cancer